Piperlongumine overcomes imatinib resistance by inducing proteasome inhibition in chronic myelogenous leukemia cells-Reference-Cited by-同舟云学术

Piperlongumine overcomes imatinib resistance by inducing proteasome inhibition in chronic myelogenous leukemia cells

Published:2023-01 Issue: Volume:301 Page:115815
ISSN:0378-8741
Container-title:Journal of Ethnopharmacology
language:en
Short-container-title:Journal of Ethnopharmacology

Author:

Lan Xiaoying,Hu Min,Jiang Liling,Wang Jiamin,Meng Yi,Chen Xinmei,Liu Aochu,Ding Wa,Zhang Haichuan,Zhou Huan,Liu Bingyuan,Peng Guanjie,Liao Siyan,Chen Xin^ORCID,Liu Jinbao,Shi Xianping

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology

Reference47 articles.

1. Bcr-Abl variants: biological and clinical aspects;Advani;Leuk. Res.,2002

2. Mechanism of direct degradation of IkappaBalpha by 20S proteasome;Alvarez-Castelao;FEBS Lett.,2005

3. Long pepper[M]//Handbook of Herbs and Spices;Babu,2006

4. Overview of the therapeutic potential of piplartine (piperlongumine);Bezerra;Eur. J. Pharmaceut. Sci.,2013

5. Piperlongumine selectively kills hepatocellular carcinoma cells and preferentially inhibits their invasion via ROS-ER-MAPKs-CHOP;Chen;Oncotarget,2015

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Herbal Medicine and Plants in the Treatment of Leukemia;Advances in Medical Diagnosis, Treatment, and Care;2024-04-19

2. Piplartine eliminates CD34 + AML stem/progenitor cells by inducing oxidative stress and suppressing NF-κB signalling;Cell Death Discovery;2024-03-19

3. Amide Alkaloids as Privileged Sources of Senomodulators for Therapeutic Purposes in Age-Related Diseases;Journal of Natural Products;2024-03-04

4. Piperlongumine inhibits antioxidant enzymes, increases ROS levels, induces DNA damage and G2/M cell cycle arrest in breast cell lines;Journal of Toxicology and Environmental Health, Part A;2024-01-27

5. Exploiting the potential of the ubiquitin-proteasome system in overcoming tyrosine kinase inhibitor resistance in chronic myeloid leukemia;Genes & Diseases;2023-10